ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
抗疫概念
919.302
-18.370
-1.96%
手动刷新
涨家数:
5
跌家数:
12
平家数:
1
市盈率:
- -
高:
937.645
开:
937.393
低:
915.979
收:
937.672
数据加载中...
总览
新闻
智通港股早知道 | 央行等部门将介绍一揽子金融政策支持稳市场稳预期 港交所推出“科企专线”
智通财经
·
05-07
白云山(00874.HK)遭LSV Asset Management减持14.4万股
格隆汇
·
05-07
脱发患者福音!开拓药业KX-826联合米诺地尔临床数据亮眼
药事纵横
·
05-07
北京藏卫信康医药研发有限公司申请III类会议
金融界
·
05-07
万春医药上涨13.77%,报1.9美元/股,总市值7660.10万美元
金融界
·
05-07
各大品牌五一假期订单量/比亚迪超10万台 魏建军回应不做增程
太平洋汽车网
·
05-07
“智驾+价格”双卷,国内汽车业进入最惨烈淘汰赛
财中社
·
05-06
2万亿阿里,撒钱入局外卖大战
21世纪商业评论
·
05-06
京东健康携手温医大附一院探索“未来数字医院”建设 推动医疗大模型落地应用
证券日报
·
05-06
欧盟贸易官员:如果扩大关税范围,美国可以征收超过1000亿美元的关税
金十财经
·
05-06
欧盟贸易官员:如果扩大关税范围,美国可以征收超过1000亿美元的关税
美港电讯
·
05-06
四环医药(00460)5月6日斥资1468.4万港元回购2000万股
智通财经
·
05-06
复星医药累计回购731.06万股A股及236.5万股H股
智通财经网
·
05-06
歌礼宣布将在第32届欧洲肥胖症大会以口头和壁报形式报告脂肪靶向、减重不减肌肥胖症候选药物ASC47研究结果
美通社
·
05-06
歌礼制药(01672)将在第32届欧洲肥胖症大会上报告ASC47早期研究成果
金吾财讯
·
05-06
歌礼制药:欧洲肥胖症大会报告ASC47研究成果
美港电讯
·
05-06
歌礼制药-B(01672)将在第32届欧洲肥胖症大会报告脂肪靶向、减重不减肌肥胖症候选药物ASC47研究结果
智通财经
·
05-06
歌礼制药(01672.HK)将公布肥胖症候选药物ASC47早期研究结果
阿斯达克财经
·
05-06
给员工加薪天经地义!刘强东:企业的价值是改善员工生活 否则没意义
快科技
·
05-06
虚构医药服务项目、协助冒名就医等,北京4家医疗机构被处罚
北京日报客户端
·
05-06
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1515/news?page=16"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":919.3017,"timestamp":1747296513223,"preClose":937.6715,"halted":0,"volume":297782532,"delay":0,"changeRate":-0.019591,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-18.369812,"latestTime":"05-15 16:00:00","open":937.39325,"high":937.6448,"low":915.97925,"amount":2228377213,"amplitude":0.023106,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747359000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1747272600000,1747281600000],[1747285200000,1747296000000]],"pbRate":1.633562,"peRate":21.843761,"turnoverRate":0.003886,"increases":6,"decrements":12,"flats":0,"marketCap":632233033536,"floatMarketCap":522016295616},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":937.6448,"amplitude":0.023106,"preClose":937.6715,"low":915.97925,"pbRate":"1.633562","latestPrice":919.3017,"volume":297782532,"delay":0,"open":937.39325,"prevYearClose":787.97723,"prevWeekClose":896.528,"prevMonthClose":903.998,"prevQuarterClose":870.015,"fiveDayClose":907.789,"twentyDayClose":840.443,"sixtyDayClose":887.079,"secType":"PLATE","market":"HK","turnoverRate":0.003886,"peRate":21.843761,"marketCap":632233033536,"floatMarketCap":522016295616,"timestamp":1747296513223,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":5,"down":12,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:16,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533910476","title":"智通港股早知道 | 央行等部门将介绍一揽子金融政策支持稳市场稳预期 港交所推出“科企专线”","url":"https://stock-news.laohu8.com/highlight/detail?id=2533910476","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533910476?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 07:18","pubTimestamp":1746573511,"startTime":"0","endTime":"0","summary":"央行等部门将介绍一揽子金融政策支持稳市场稳预期国务院新闻办公室将于5月7日上午9时举行新闻发布会,请中国人民银行、国家金融监督管理总局、中国证券监督管理委员会负责人介绍“一揽子金融政策支持稳市场稳预期”有关情况,并答记者问。欧盟周二表示,特朗普正在进行的贸易调查将使欧盟面临关税的商品数额增加到5490亿欧元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"17880f2c2ca17d5d1327fe3b361a8f90","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1574","BK1183","YANG","HSTECH","02432","BK1161","HSCEI","BK4614","BK1515","159940","BK1191","00512"],"gpt_icon":1},{"id":"2533295691","title":"白云山(00874.HK)遭LSV Asset Management减持14.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533295691","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533295691?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 06:53","pubTimestamp":1746572015,"startTime":"0","endTime":"0","summary":"格隆汇5月7日丨根据联交所最新权益披露资料显示,2025年4月30日,白云山(00874.HK)遭LSV Asset Management在场内以每股均价16.8867港元减持14.4万股,涉资约243.17万港元。减持后,LSV Asset Management最新持股数目为10,893,111股,持股比例由5.02%下降至4.95%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/07065350177520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["600332","BK0183","BK1515","BK0097","BK1191","BK0175","BK0028","BK0188","BK0070","00874","BK0196","BK0012","BK0239","BK1197","BK1521","BK0096","BK1606"],"gpt_icon":0},{"id":"2533689691","title":"脱发患者福音!开拓药业KX-826联合米诺地尔临床数据亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2533689691","media":"药事纵横","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533689691?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 06:04","pubTimestamp":1746569045,"startTime":"0","endTime":"0","summary":"5月2日,开拓药业发布的临床观察试验结果显示,其自主研发的KX-826联合米诺地尔治疗中国成年男性雄激素性脱发的疗效显著优于米诺地尔单药。图源:开拓药业官方公告此次试验共纳入75例患者,联合用药组(40例)采用0.5% KX-826酊联合5%米诺地尔酊每日两次外用,单药组(35例)仅使用5%米诺地尔酊。开拓药业的联合疗法若成功上市,有望填补这一空白。长远来看,若III期成功,KX-826联合疗法有望成为首个基于AR拮抗机制的AGA疗法,抢占千亿市场先机。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507064914a474879e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507064914a474879e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","BK1515","02487","BK1574"],"gpt_icon":0},{"id":"2533698902","title":"北京藏卫信康医药研发有限公司申请III类会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2533698902","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533698902?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 05:06","pubTimestamp":1746565597,"startTime":"0","endTime":"0","summary":"北京藏卫信康医药研发有限公司,成立于2014年,位于北京市,是一家以从事研究和试验发展为主的企业。通过天眼查大数据分析,北京藏卫信康医药研发有限公司参与招投标项目1次,知识产权方面有商标信息51条,专利信息21条,此外企业还拥有行政许可9个。主要股东信息显示,北京藏卫信康医药研发有限公司由西藏卫信康医药股份有限公司持股100%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/07050650177282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4134","BK0239","603676","BK0191","BK1574","159938","09939","BK1161","III","BK1515"],"gpt_icon":0},{"id":"2533766151","title":"万春医药上涨13.77%,报1.9美元/股,总市值7660.10万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533766151","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533766151?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 03:44","pubTimestamp":1746560653,"startTime":"0","endTime":"0","summary":"5月7日,万春医药盘中上涨13.77%,截至03:44,报1.9美元/股,成交4.61万美元,总市值7660.10万美元。财务数据显示,截至2024年06月30日,万春医药收入总额100.0万美元,同比增长14.29%;归母净利润-726.2万美元,同比增长42.91%。大事提醒:5月5日,万春医药将披露2024财年年报。资料显示,万春药业公司是一家处于全球临床阶段的生物制药公司,专注于新型癌症疗法,包括晚期肿瘤免疫药物的研发。公司成立于2013年,总部设立在美国。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/07034450177152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09939","BK1161","BK1574","BK1515","159938"],"gpt_icon":0},{"id":"2533650906","title":"各大品牌五一假期订单量/比亚迪超10万台 魏建军回应不做增程","url":"https://stock-news.laohu8.com/highlight/detail?id=2533650906","media":"太平洋汽车网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533650906?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 01:11","pubTimestamp":1746551469,"startTime":"0","endTime":"0","summary":"今日车闻包括五一假期各大车企订单数量、别克GL8陆尚累计大定破万、领克09限时售21.08万起、魏建军回应长城汽车不做增程、阿维塔官方回应风阻系数争议、上汽集团4月销量、长安汽车4月销量、极氪集团人事调整。五一假期各大车企大定量比亚迪新增订单10万台根据汽车达人@孙少军09爆料,五一假期前后,比亚迪新增订单10万台左右;理想汽车新增订单1.4万台左右;小鹏汽车新增订单1万台左右。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507012234a6d548e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507012234a6d548e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0511384066.AUD","601633","LU1242518857.USD","LU0593848301.USD","LU2097828714.EUR","LU0449509016.USD","LU0348767384.USD","LU0531971595.HKD","GWLLY","002594","LU0289739343.SGD","LU2476274308.USD","LU0561508036.HKD","LU1719994722.HKD","LU0516422440.USD","LU0823426480.USD","LU0588545490.SGD","01211","BK1515","LU0634319403.HKD","81211","BYDDY","SG9999006597.SGD","SG9999014674.SGD","LU1868837565.USD","LU0505663152.USD","LU0531970944.HKD","82333","02333","LU0254981946.USD","LU0175139822.USD","LU1242518931.SGD","LU2476274720.SGD","LU0516423174.USD","SG9999015952.SGD","HYDD.SI","LU0143863198.USD","LU0164865239.USD","LU2097828557.USD","LU0211977185.USD","LU1794554557.SGD","LU0871576103.HKD","LU1868838027.USD","LU1770034418.SGD","LU0449515922.USD","LU0865486749.SGD","LU0327786744.USD","LU0348805143.USD","00285","BK1607"],"gpt_icon":1},{"id":"2533632639","title":"“智驾+价格”双卷,国内汽车业进入最惨烈淘汰赛","url":"https://stock-news.laohu8.com/highlight/detail?id=2533632639","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533632639?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 21:02","pubTimestamp":1746536577,"startTime":"0","endTime":"0","summary":"4月,中国乘用车市场“变天”了。乘联会数据显示,4月份新能源汽车零售渗透率突破了50%,正式在零售端超越了传统燃油车。这个速度超出了所有人预期和最乐观估计。两年前,德勤曾在报告中指出,2022年全年,中国新能源汽车销售实现25.6%的渗透率,提前3年完成既定目标,新能源汽车零售渗透率有望进一步稳步提升,到2025年超过40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505063397042715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00285","BYDDY","LU1242518931.SGD","LU1303224171.USD","BK1580","LU0819121731.USD","LU1861214812.USD","BK1515","LU0039217434.USD","LU0594300419.USD","IE00BD6J9T35.USD","LU0289739343.SGD","LU0979878070.USD","LU0084288322.USD","LU0269904917.USD","LU0593848301.USD","002594","LU1770034418.SGD","LU0823414478.USD","LU1251922891.USD","BK1582","LU1794554557.SGD","09863","LU0359201612.USD","LU0348805143.USD","LU0588545490.SGD","LU0531970944.HKD","SG9999001226.SGD","LU0588545904.SGD","LU0588546209.SGD","LU1961090484.USD","LU0594300179.USD","LU1861219969.SGD","LU0572944931.SGD","LU0449509016.USD","LU0856984785.SGD","SG9999015952.SGD","81211","LU0463099449.HKD","SG9999006597.SGD","LU2153592121.USD","SG9999006514.SGD","LU0516422366.SGD","01211","LU0320764599.SGD","LU0254981946.USD","LU0348766576.USD","LU1808992512.USD","LU2249611893.SGD","HYDD.SI"],"gpt_icon":1},{"id":"2533264979","title":"2万亿阿里,撒钱入局外卖大战","url":"https://stock-news.laohu8.com/highlight/detail?id=2533264979","media":"21世纪商业评论","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533264979?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 21:02","pubTimestamp":1746536520,"startTime":"0","endTime":"0","summary":"后发入场的淘宝闪购,狂撒补贴,阿里集团市值超2万亿人民币, CEO吴泳铭给足预算,防止在这波大战中失语。补贴重点指向奶茶、餐食等高频场景,这是此前外卖补贴战的重点方向。2抢占时机阿里管理层,最终选择不再旁观。4月中旬,外卖大战正酣,饿了么扮演“观战方”,称“不打口水仗”。其预测,到2030年,该行业规模将达到2万亿元。3个月后,饿了么宣布,计划开设10万家近场品牌的官方旗舰店。此时加入补贴大战,亏损或将扩大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506211801a6d5160a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506211801a6d5160a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2087589342.USD","BK1515","LU0650527681.SGD","LU0456846285.SGD","LU0164865239.USD","LU0823397285.USD","LU1807302812.USD","LU1808992512.USD","LU0163747925.USD","LU0165289439.USD","89988","SG9999001226.SGD","LU0320764243.SGD","LU0531971595.HKD","LU0029874905.USD","LU0516422366.SGD","00241","LU0640798160.USD","IE00BZ08YT58.USD","LU1044876610.USD","LU0127658192.USD","HBBD.SI","LU0307460666.USD","LU0173614495.USD","LU0320764755.SGD","IE00B543WZ88.USD","LU1770036033.HKD","LU1868837565.USD","LU2152927971.USD","BABA","LU1515016050.SGD","LU0370786039.SGD","LU0651946864.USD","LU0229945570.USD","LU2242644610.SGD","IE0032431581.USD","LU0531970944.HKD","BK1571","IE00B3M56506.USD","LU1719994722.HKD","LU0228367735.SGD","LU0634319403.HKD","LU0314109678.HKD","LU0543330483.HKD","LU0823040885.USD","LU0577902454.USD","LU1323998911.USD","LU0348788117.USD","09988","LU1044875133.USD"],"gpt_icon":0},{"id":"2533716684","title":"京东健康携手温医大附一院探索“未来数字医院”建设 推动医疗大模型落地应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2533716684","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533716684?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 19:39","pubTimestamp":1746531577,"startTime":"0","endTime":"0","summary":"本报讯(记者袁传玺)在日前由中国医院协会举办的“公立医院运营效能提升与创新发展”研讨会上,温州医科大学附属第一医院(以下简称“温医大附一院”)全面介绍了该院智慧医院建设的进展情况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505063396971472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1247","BK1515","BK1589","BK1615","BK1571","LU0456827905.SGD","LU0051755006.USD","BK1583","06618","BK1591","BK1142","86618"],"gpt_icon":0},{"id":"2533507786","title":"欧盟贸易官员:如果扩大关税范围,美国可以征收超过1000亿美元的关税","url":"https://stock-news.laohu8.com/highlight/detail?id=2533507786","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533507786?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 18:25","pubTimestamp":1746527152,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["EURmain","09939","FXE","159938","BK1515","MEURmain","159582","BK1574","EUO","HGmain","BK1161"],"gpt_icon":0},{"id":"2533214507","title":"欧盟贸易官员:如果扩大关税范围,美国可以征收超过1000亿美元的关税","url":"https://stock-news.laohu8.com/highlight/detail?id=2533214507","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533214507?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 18:25","pubTimestamp":1746527152,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1574","HGmain","EUO","159938","159582","BK1515","09939","EURmain","FXE","MEURmain","BK1161"],"gpt_icon":0},{"id":"2533996506","title":"四环医药(00460)5月6日斥资1468.4万港元回购2000万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533996506","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533996506?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 17:43","pubTimestamp":1746524639,"startTime":"0","endTime":"0","summary":"智通财经APP讯,四环医药(00460)发布公告,于2025年5月6日,该公司斥资1468.4万港元回购2000万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"四环医药(00460)5月6日斥资1468.4万港元回购2000万股","news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1600","00460","BK1515","BK1593"],"gpt_icon":0},{"id":"2533505263","title":"复星医药累计回购731.06万股A股及236.5万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533505263","media":"智通财经网","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533505263?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 17:09","pubTimestamp":1746522548,"startTime":"0","endTime":"0","summary":"截至2025年4月30日收市,于A股回购方案下,公司已累计回购731.06万股A股,累计回购金额约为人民币1.75亿元,最高价人民币25.39元/股、最低价人民币23.34元/股。2025年4月当月,公司回购共计70.95万股H股,回购总金额合计约为港币996.98万元,最高价港币14.30元/股、最低价港币13.94元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050617111097507a44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050617111097507a44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","02196","BK1191","BK1593"],"gpt_icon":0},{"id":"2533730570","title":"歌礼宣布将在第32届欧洲肥胖症大会以口头和壁报形式报告脂肪靶向、减重不减肌肥胖症候选药物ASC47研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533730570","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533730570?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 16:55","pubTimestamp":1746521700,"startTime":"0","endTime":"0","summary":"香港 2025年5月6日 /美通社/ -- 歌礼制药有限公司今日宣布将在西班牙马拉加举行的第32届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物ASC47的早期研究。口头报告细节 标题:脂肪靶向、减重不减肌的肥胖症候选药物ASC47在DIO小鼠中显示出显著的减重效果,且不减肌 摘要类别 / 主题:肥胖症管理和干预新兴疗法 摘要编号:0254 会议:T1摘要报告环节:新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4680668_ZH80668_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1515","BK1161","01672","BK1574"],"gpt_icon":0},{"id":"2533749915","title":"歌礼制药(01672)将在第32届欧洲肥胖症大会上报告ASC47早期研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533749915","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533749915?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 16:51","pubTimestamp":1746521494,"startTime":"0","endTime":"0","summary":"金吾财讯 | 歌礼制药 宣布,将在西班牙马拉加举行的第32届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物ASC47的早期研究。ASC47是一款由歌礼自主研发的、脂肪靶向、超长效皮下注射的甲状腺激素受体β选择性小分子激动剂。ASC47具有独特的差异化特性,能够靶向脂肪,从而在脂肪组织中产生剂量依赖性的高药物浓度。美国食品药品监督管理局已批准ASC47与司美格鲁肽联用治疗肥胖症的新药临床试验申请。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/Y2MwODZhYWZmNGQzMDgwOTQyYjU5NWM2YWIxYjEyMTA4MTkwNzMzNjk5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2MwODZhYWZmNGQzMDgwOTQyYjU5NWM2YWIxYjEyMTA4MTkwNzMzNjk5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1958181","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1515","BK1161","BK1191","01477","BK1574"],"gpt_icon":0},{"id":"2533579335","title":"歌礼制药:欧洲肥胖症大会报告ASC47研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533579335","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533579335?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 16:43","pubTimestamp":1746520990,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1191","01477","BK1161","BK1515","BK1576","BK1583","BK1574","03347","BK1141","01672"],"gpt_icon":0},{"id":"2533798085","title":"歌礼制药-B(01672)将在第32届欧洲肥胖症大会报告脂肪靶向、减重不减肌肥胖症候选药物ASC47研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533798085","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533798085?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 16:42","pubTimestamp":1746520946,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B 公布,将在西班牙马拉加举行的第32届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物ASC47的早期研究。ASC47是一款由歌礼自主研发的、脂肪靶向、超长效皮下注射的甲状腺激素受体β选择性小分子激动剂。ASC47具有独特的差异化特性,能够靶向脂肪,从而在脂肪组织中产生剂量依赖性的高药物浓度。美国食品药品监督管理局已批准ASC47与司美格鲁肽联用治疗肥胖症的新药临床试验申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01672","BK1515","BK1574","01477","BK1191"],"gpt_icon":0},{"id":"2533571198","title":"歌礼制药(01672.HK)将公布肥胖症候选药物ASC47早期研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533571198","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533571198?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 16:42","pubTimestamp":1746520920,"startTime":"0","endTime":"0","summary":"歌礼制药(01672.HK) 公布,将在西班牙马拉加举行的第32届欧洲肥胖症大会(ECO 2025)上,以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物ASC47的早期研究结果。目前美国食品药品监督管理局(FDA)已批准ASC47与司美格鲁肽联用治疗肥胖症的新药临床试验申请。(ss/a)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200428112816451_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200428112816451_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1438006/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1515","BK1161","BK1574","01477","01672"],"gpt_icon":0},{"id":"2533523586","title":"给员工加薪天经地义!刘强东:企业的价值是改善员工生活 否则没意义","url":"https://stock-news.laohu8.com/highlight/detail?id=2533523586","media":"快科技","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533523586?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 14:21","pubTimestamp":1746512510,"startTime":"0","endTime":"0","summary":"【给员工加薪天经地义!刘强东:企业的价值是改善员工生活 否则没意义】近日中国人民大学校友会发布刘强东相关视频,刘强东称:“你创业为了什么?做企业目的是什么?如果不能为社会创造价值、不能为行业创造价值,那么你就不是一个实事求是的态度。你的员工过来的时候,你不能让他生活的有尊严、不能够改善他的生活,不仅是个人的生活,包括他整个家庭的生活质量的话,那么我觉得,所有企业可能存在的价值也没有。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.eastmoney.com/a/202505063396661257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0370786039.SGD","LU0048580855.USD","LU0708995583.HKD","LU1719994722.HKD","LU0128522157.USD","LU0359201612.USD","LU0868486357.SGD","JD","BK4558","BK1591","LU0163747925.USD","LU0140636845.USD","LU0327786744.USD","09618","86618","IE00B29SXG58.USD","BK1583","LU0052750758.USD","SG9999002463.SGD","BK1571","BK1515","BK4524","BK4588","LU0499858602.USD","LU0588545730.USD","LU0051755006.USD","LU0307460666.USD","06618","LU0293314216.USD","LU0326950275.SGD","LU0345775950.USD","LU0315178854.USD","LU0469268626.HKD","LU0456827905.SGD","LU0588545490.SGD","BK1589","LU0791590937.USD","LU1366334651.USD","LU0164865239.USD","LU1188198961.HKD","LU0499858438.USD","IE0032431581.USD","LU1303224171.USD","LU1044874839.SGD","89618","LU0588545904.SGD","SG9999002562.SGD","BK4585","SG9999001226.SGD","LU1251922891.USD"],"gpt_icon":1},{"id":"2533540943","title":"虚构医药服务项目、协助冒名就医等,北京4家医疗机构被处罚","url":"https://stock-news.laohu8.com/highlight/detail?id=2533540943","media":"北京日报客户端","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533540943?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 14:06","pubTimestamp":1746511560,"startTime":"0","endTime":"0","summary":"北京市医保局近日公布4月医疗机构行政处罚决定,北京京北医院等4家医疗机构因虚构医药服务项目、协助冒名就医等违法行为被罚款。北京京北医院、北京华生康复医院有限公司、北京四惠中医医院等机构因医保基金使用不规范问题被通报。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/chanjing/gsnews/2025-05-06/doc-inevrenz0670118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","159938","BK1161","BK1574","09939"],"gpt_icon":0}],"pageSize":20,"totalPage":19,"pageCount":16,"totalSize":371,"code":"91000000","status":"200"}]}}